213 related articles for article (PubMed ID: 7818636)
1. Apolipoprotein E4 and Alzheimer's disease pathology in Lewy body disease and in other beta-amyloid-forming diseases.
Pickering-Brown SM; Mann DM; Bourke JP; Roberts DA; Balderson D; Burns A; Byrne J; Owen F
Lancet; 1994 May; 343(8906):1155. PubMed ID: 7818636
[No Abstract] [Full Text] [Related]
2. Apolipoprotein E gene in diffuse Lewy body disease with or without co-existing Alzheimer's disease.
Arai H; Higuchi S; Muramatsu T; Iwatsubo T; Sasaki H; Trojanowski JQ
Lancet; 1994 Nov; 344(8932):1307. PubMed ID: 7818703
[No Abstract] [Full Text] [Related]
3. A quartet of Down's syndrome, Alzheimer's disease, cerebral amyloid angiopathy, and cerebral haemorrhage: interacting genetic risk factors.
McCarron MO; Nicoll JA; Graham DI
J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):405-6. PubMed ID: 9728967
[No Abstract] [Full Text] [Related]
4. Apolipoprotein E, A beta-amyloid, and the molecular pathology of Alzheimer's disease. Therapeutic implications.
Kaplitt M; Gouras GK; Makimura H; Jovanovic J; Sweeney D; Greengard P; Relkin NR; Gandy S
Ann N Y Acad Sci; 1996 Dec; 802():42-9. PubMed ID: 8993483
[No Abstract] [Full Text] [Related]
5. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E epsilon 4 allele frequency in patients with Lewy body dementia, Alzheimer's disease and age-matched controls.
St Clair D; Norrman J; Perry R; Yates C; Wilcock G; Brookes A
Neurosci Lett; 1994 Jul; 176(1):45-6. PubMed ID: 7970234
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases.
Saunders AM; Schmader K; Breitner JC; Benson MD; Brown WT; Goldfarb L; Goldgaber D; Manwaring MG; Szymanski MH; McCown N
Lancet; 1993 Sep; 342(8873):710-1. PubMed ID: 8103823
[TBL] [Abstract][Full Text] [Related]
8. Lower frequency of apolipoprotein E4 allele in an "elderly" Down's syndrome population.
Cosgrave M; Tyrrell J; Dreja H; Hawi Z; Lawlor BA; Gill M
Biol Psychiatry; 1996 Oct; 40(8):811-3. PubMed ID: 8894078
[No Abstract] [Full Text] [Related]
9. Apolipoprotein E genotype and Lewy body disease.
Lippa CF; Smith TW; Saunders AM; Crook R; Pulaski-Salo D; Davies P; Hardy J; Roses AD; Dickson D
Neurology; 1995 Jan; 45(1):97-103. PubMed ID: 7824144
[TBL] [Abstract][Full Text] [Related]
10. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
[TBL] [Abstract][Full Text] [Related]
11. APOE in Alzheimer's disease and neurodegeneration.
Butterfield DA; Johnson LA
Neurobiol Dis; 2020 Jun; 139():104847. PubMed ID: 32209402
[No Abstract] [Full Text] [Related]
12. MR spectroscopy, APOE genotype, and evolving β-amyloid pathology: What is being detected and when.
Kantarci K; Goldberg TE
Neurology; 2016 May; 86(19):1750-1. PubMed ID: 27164709
[No Abstract] [Full Text] [Related]
13. New piece in Alzheimer's puzzle.
Travis J
Science; 1993 Aug; 261(5123):828-9. PubMed ID: 8346434
[No Abstract] [Full Text] [Related]
14. Clinical and neuropathological correlates of apolipoprotein E genotype in Alzheimer's disease. Window on molecular epidemiology.
Hyman BT; Gomez-Isla T; West H; Briggs M; Chung H; Growdon JH; Rebeck GW
Ann N Y Acad Sci; 1996 Jan; 777():158-65. PubMed ID: 8624079
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's disease, Down's syndrome, and chromosome segregation.
Potter H; Geller LN
Lancet; 1996 Jul; 348(9019):66. PubMed ID: 8691961
[No Abstract] [Full Text] [Related]
16. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease.
Harrington CR; Louwagie J; Rossau R; Vanmechelen E; Perry RH; Perry EK; Xuereb JH; Roth M; Wischik CM
Am J Pathol; 1994 Dec; 145(6):1472-84. PubMed ID: 7992850
[TBL] [Abstract][Full Text] [Related]
17. Genetic susceptibility to Alzheimer disease.
Pericak-Vance MA; Haines JL
Trends Genet; 1995 Dec; 11(12):504-8. PubMed ID: 8533168
[TBL] [Abstract][Full Text] [Related]
18. The effect of apolipoprotein E genotype on biochemical markers of Alzheimer's disease.
Schenk D; Lieberburg I; Motter R; Seubert P
Ann N Y Acad Sci; 1996 Dec; 802():92-100. PubMed ID: 8993488
[No Abstract] [Full Text] [Related]
19. Apolipoprotein E genotype and Alzheimer's disease.
Noguchi S; Murakami K; Yamada N
Lancet; 1993 Sep; 342(8873):737. PubMed ID: 8103832
[No Abstract] [Full Text] [Related]
20. Senile dementia of the Lewy body type has an apolipoprotein E epsilon 4 allele frequency intermediate between controls and Alzheimer's disease.
Hardy J; Crook R; Prihar G; Roberts G; Raghavan R; Perry R
Neurosci Lett; 1994 Nov; 182(1):1-2. PubMed ID: 7891871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
